Publication | Open Access
Efficacy of immune checkpoint inhibitors for in-transit melanoma
35
Citations
11
References
2020
Year
ICI produce objective responses in ITM and should be considered in patients with unresectable ITM or disease recurrence.
| Year | Citations | |
|---|---|---|
Page 1
Page 1